| Title： | Expert consensus on the evaluation of shortage of Chinese patent medicine |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | Relevant medical institutions. |
| Evidence classification method： | This study is based on expert consensus and does not set evidence grading method |
| Development unit： | Xuanwu Hospital of Capital Medical University; Beijing Center for Drug Use Monitoring and Clinical Comprehensive Evaluation |
| Registration time: | 2024-04-10 |
| Registration number： | PREPARE-2024CN517 |
| Purpose of the guideline: | In order to guide medical institutions to objectively and fairly evaluate the shortage of Chinese patent medicines, promote the supply guarantee of drugs in medical institutions, and guarantee patients receive safe, effective, economic and stable drug treatment, this expert consensus was formulated. |
